TY - JOUR
T1 - Developing expert international consensus statements for opioid-sparing analgesia using the Delphi method
AU - Sng, Daniel Da Der
AU - Uitenbosch, Giulia
AU - de Boer, Hans D.
AU - Carvalho, Hugo Nogueira
AU - Cata, Juan P.
AU - Erdoes, Gabor
AU - Heytens, Luc
AU - Lois, Fernande Jane
AU - Pelosi, Paolo
AU - Rousseau, Anne Françoise
AU - Forget, Patrice
AU - Nesvadba, David
AU - Abdolmohammadi, Sadegh
AU - Asfaw, Gebrehiwot
AU - Benhamou, Daniel
AU - Blaise, Gilbert
AU - Cuvillon, Philippe
AU - Tahan, Mohamed El
AU - Feldano, Emmanuel
AU - Fettes, Paul
AU - Finco, Gabriele
AU - Fitzpatrick, Michael
AU - Kapila, Atul
AU - Kaye, Callum
AU - Kaura, Vikas
AU - May, Helen
AU - Meybohm, Patrick
AU - Stamer, Ulrike
AU - Taylor, Daniel
AU - Van De Velde, Marc
AU - Van Pee, Benoit
AU - Pain AND Opioids after Surgery (PANDOS) European Society of Anaesthesiology, Intensive Care (ESAIC) Research Group
N1 - Funding Information:
We would like to thank our supervisors, panellists and contributors for making this project possible.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/2/27
Y1 - 2023/2/27
N2 - INTRODUCTION: The management of postoperative pain in anaesthesia is evolving with a deeper understanding of associating multiple modalities and analgesic medications. However, the motivations and barriers regarding the adoption of opioid-sparing analgesia are not well known.METHODS: We designed a modified Delphi survey to explore the perspectives and opinions of expert panellists with regard to opioid-sparing multimodal analgesia. 29 anaesthetists underwent an evolving three-round questionnaire to determine the level of agreement on certain aspects of multimodal analgesia, with the last round deciding if each statement was a priority.RESULTS: The results were aggregated and a consensus, defined as achievement of over 75% on the Likert scale, was reached for five out of eight statements. The panellists agreed there was a strong body of evidence supporting opioid-sparing multimodal analgesia. However, there existed multiple barriers to widespread adoption, foremost the lack of training and education, as well as the reluctance to change existing practices. Practical issues such as cost effectiveness, increased workload, or the lack of supply of anaesthetic agents were not perceived to be as critical in preventing adoption.CONCLUSION: Thus, a focus on developing specific guidelines for multimodal analgesia and addressing gaps in education may improve the adoption of opioid-sparing analgesia.
AB - INTRODUCTION: The management of postoperative pain in anaesthesia is evolving with a deeper understanding of associating multiple modalities and analgesic medications. However, the motivations and barriers regarding the adoption of opioid-sparing analgesia are not well known.METHODS: We designed a modified Delphi survey to explore the perspectives and opinions of expert panellists with regard to opioid-sparing multimodal analgesia. 29 anaesthetists underwent an evolving three-round questionnaire to determine the level of agreement on certain aspects of multimodal analgesia, with the last round deciding if each statement was a priority.RESULTS: The results were aggregated and a consensus, defined as achievement of over 75% on the Likert scale, was reached for five out of eight statements. The panellists agreed there was a strong body of evidence supporting opioid-sparing multimodal analgesia. However, there existed multiple barriers to widespread adoption, foremost the lack of training and education, as well as the reluctance to change existing practices. Practical issues such as cost effectiveness, increased workload, or the lack of supply of anaesthetic agents were not perceived to be as critical in preventing adoption.CONCLUSION: Thus, a focus on developing specific guidelines for multimodal analgesia and addressing gaps in education may improve the adoption of opioid-sparing analgesia.
KW - Analgesics, Opioid/therapeutic use
KW - Delphi Technique
KW - Educational Status
KW - Analgesia
KW - Pain Management
UR - http://www.scopus.com/inward/record.url?scp=85148971967&partnerID=8YFLogxK
U2 - 10.1186/s12871-023-01995-4
DO - 10.1186/s12871-023-01995-4
M3 - Article
C2 - 36849928
SN - 1471-2253
VL - 23
JO - BMC Anesthesiology
JF - BMC Anesthesiology
IS - 1
M1 - 62
ER -